Literature DB >> 18160364

Aspirin and gastrointestinal toxicity.

Murat Törüner1.   

Abstract

Aspirin is the main actor in primary and secondary preventive treatments in cardiovascular diseases. However, it has several side effects including gastrointestinal toxicity (peptic ulcer formation, bleeding). Although lower doses are relatively safe, we should keep in mind that even the lowest dose may cause gastrointestinal bleeding. Gastrointestinal toxicity profile does not differ between conventional and enteric-coated aspirin use. In patients who have cardiovascular disease but are at high risk for gastrointestinal bleeding, eradication of Helicobacter pylori infection and concurrent proton pump inhibitor therapy may help to reduce the risk of gastrointestinal toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160364

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  2 in total

Review 1.  Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review.

Authors:  Hanan Muzeyin Kedir; Eskinder Ayalew Sisay; Alfoalem Araba Abiye
Journal:  Int J Gen Med       Date:  2021-08-24

2.  Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity.

Authors:  Deepkamal N Karelia; Sangyub Kim; Manoj K Pandey; Daniel Plano; Shantu Amin; Junxuan Lu; Arun K Sharma
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.